These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 19906075)

  • 1. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema.
    Bissonnette R; Worm M; Gerlach B; Guenther L; Cambazard F; Ruzicka T; Maares J; Brown TC
    Br J Dermatol; 2010 Feb; 162(2):420-6. PubMed ID: 19906075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extended treatment with oral alitretinoin for patients with chronic hand eczema not fully responding to initial treatment.
    Lynde C; Cambazard F; Ruzicka T; Sebastian M; Brown TC; Maares J
    Clin Exp Dermatol; 2012 Oct; 37(7):712-7. PubMed ID: 22731739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.
    Ruzicka T; Lynde CW; Jemec GB; Diepgen T; Berth-Jones J; Coenraads PJ; Kaszuba A; Bissonnette R; Varjonen E; Holló P; Cambazard F; Lahfa M; Elsner P; Nyberg F; Svensson A; Brown TC; Harsch M; Maares J
    Br J Dermatol; 2008 Apr; 158(4):808-17. PubMed ID: 18294310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids.
    Dirschka T; Reich K; Bissonnette R; Maares J; Brown T; Diepgen TL
    Clin Exp Dermatol; 2011 Mar; 36(2):149-54. PubMed ID: 21070335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy.
    Fowler JF; Graff O; Hamedani AG
    J Drugs Dermatol; 2014 Oct; 13(10):1198-204. PubMed ID: 25607554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alitretinoin for the treatment of severe chronic hand eczema.
    Paulden M; Rodgers M; Griffin S; Slack R; Duffy S; Ingram JR; Woolacott N; Sculpher M
    Health Technol Assess; 2010 May; 14 Suppl 1():39-46. PubMed ID: 20507802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Alitretinoin in chronic hand eczema: summary of clinical trials].
    Richard MA
    Ann Dermatol Venereol; 2010 Nov; 137 Suppl 3():S111-23. PubMed ID: 21185982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alitretinoin for severe chronic hand eczema: a NICE single technology appraisal.
    Rodgers M; Griffin S; Paulden M; Slack R; Duffy S; Ingram JR; Woolacott N; Sculpher M
    Pharmacoeconomics; 2010; 28(5):351-62. PubMed ID: 20131924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics, efficacy and safety of alitretinoin in moderate or severe chronic hand eczema.
    Schmitt-Hoffmann AH; Roos B; Sauer J; Spickermann J; Stoeckel K; Edwards D; van de Wetering J; Coenraads PJ; Maares J
    Clin Exp Dermatol; 2011 Apr; 36 Suppl 2():29-34. PubMed ID: 21443602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Everyday clinical experience of alitretinoin in the treatment of severe chronic hand eczema: seven case studies.
    English J; Graham-Brown R; de Sica Chapman A; Alexandroff AB
    Clin Exp Dermatol; 2011 Mar; 36 Suppl():1-2. PubMed ID: 21309810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alitretinoin: A Review in Severe Chronic Hand Eczema.
    Blair HA; Scott LJ
    Drugs; 2016 Sep; 76(13):1271-1279. PubMed ID: 27438290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Response to treatment with oral alitretinoin in patients with chronic hand eczema that is refractory to treatment with potent topical corticosteroids: experience in 15 patients].
    Aguayo-Leiva IR; Urrutia S; Jaén-Olasolo P
    Actas Dermosifiliogr; 2011 Oct; 102(8):616-22. PubMed ID: 21354545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation and assessment of the therapeutic efficacy of alitretinoin in a group of patients with chronic hand eczema refractory to topical steroid therapy.
    Gola M; Milanesi N; D'Erme AM
    G Ital Dermatol Venereol; 2014 Aug; 149(4):435-9. PubMed ID: 25068232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial.
    Ruzicka T; Larsen FG; Galewicz D; Horváth A; Coenraads PJ; Thestrup-Pedersen K; Ortonne JP; Zouboulis CC; Harsch M; Brown TC; Zultak M
    Arch Dermatol; 2004 Dec; 140(12):1453-9. PubMed ID: 15611422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alitretinoin: a new treatment option for chronic refractory hand eczema].
    Molin S; Ruzicka T
    Hautarzt; 2008 Sep; 59(9):703-4, 706-9. PubMed ID: 18704345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alitretinoin on quality of life of patients having chronic hand eczema: an observational study.
    Gola M; D'Erme AM; Milanesi N; Marmugi L
    Dermatitis; 2013; 24(4):166-9. PubMed ID: 23857016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Off-label use of alitretinoin].
    Fritz K; Tiplica GS; Salavastru C; Onder M
    Hautarzt; 2013 Oct; 64(10):748-51. PubMed ID: 24150823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of alitretinoin in severe chronic hand eczema: PASSION, a real-world observational study.
    Thaçi D; Augustin M; Westermayer B; Kamps A; Hennig M
    J Dermatolog Treat; 2016 Nov; 27(6):577-583. PubMed ID: 27618281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Study of Efficacy Between Cyclosporine and Alitretinoin in Patients With Chronic Hand Eczema.
    Jang JH; Joh HC; Song CH; Kim KY; Jue MS; Ro YS; Ko JY
    Dermatitis; 2024; 35(3):258-265. PubMed ID: 37870578
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of systemic alitretinoin treatment on skin barrier gene and protein expression in patients with chronic hand eczema.
    Kumari V; Timm K; Kühl AA; Heine G; Worm M
    Br J Dermatol; 2016 Dec; 175(6):1243-1250. PubMed ID: 27480504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.